You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 69367-0615


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 69367-0615

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

69367-0615 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 69367-0615

Overview of the Drug

The drug with the NDC code 69367-0615 is Salsalate, a nonsteroidal anti-inflammatory drug (NSAID) manufactured by Westminster Pharmaceuticals, LLC. Salsalate is used to treat pain, inflammation, and arthritis.

Market Context

To analyze the market and price projections for Salsalate, it is essential to consider the broader pharmaceutical market trends.

General Pharmaceutical Market Trends

  • The pharmaceutical market is expected to see a 3.8% increase in drug prices, driven largely by specialty pharmaceuticals, according to Vizient's Pharmacy Market Outlook for 2024[2].
  • Specialty pharmaceuticals, which include high-cost, complex, or chronic condition treatments, are a significant driver of this price increase.
  • However, generic drugs and biosimilars are expected to play a crucial role in moderating price increases, with biosimilars projected to increase in market share and reduce costs for certain medications[2].

Impact of Generic and Biosimilar Drugs

  • The presence of generic and biosimilar drugs can significantly impact the pricing and market share of branded drugs. For instance, biosimilars are expected to grow in market share, particularly for drugs like Humira®, which could affect the pricing dynamics of similar medications[2].
  • However, Salsalate, being a generic NSAID, is less likely to be directly impacted by the biosimilar market but could still face competition from other generic NSAIDs.

Pricing Projections

Current Pricing

  • As a generic drug, Salsalate is generally priced lower than its branded counterparts. The current pricing for Salsalate can vary based on the dosage, form, and distribution channel.

Future Pricing Trends

  • Given the overall trend of moderate price increases in the pharmaceutical market, it is likely that the price of Salsalate will see a slight increase, but this will be minimal compared to specialty pharmaceuticals.
  • The projected 3.8% increase in drug prices may not significantly affect generic drugs like Salsalate, as their prices are already relatively stable and competitive[2].

Market Competition

Generic NSAIDs Market

  • The market for generic NSAIDs is highly competitive, with multiple manufacturers offering similar products. This competition helps keep prices stable and competitive.
  • Westminster Pharmaceuticals, LLC, the manufacturer of Salsalate with NDC 69367-0615, operates in a crowded market where pricing strategies are crucial to maintaining market share[1].

Patent and Exclusivity

  • Since Salsalate is a generic drug, it does not face the same patent expiration issues as branded drugs. However, the overall pharmaceutical market is experiencing a significant loss of exclusivity due to expiring patents, which could indirectly affect the pricing and availability of certain medications[3].

Sales and Revenue Projections

Sales Volume

  • The sales volume of Salsalate is likely to remain stable due to its established use in treating pain and inflammation. However, it may face fluctuations based on market demand and the introduction of new treatments.

Revenue

  • Revenue projections for Salsalate will be influenced by the overall market trends, including the moderate price increases and the competitive landscape of generic NSAIDs.
  • Given the stable nature of the generic drug market, revenue is expected to remain relatively consistent, with minor adjustments based on market dynamics.

Key Takeaways

  • Pricing Stability: Salsalate, as a generic drug, is expected to maintain stable pricing with minimal increases.
  • Market Competition: The generic NSAIDs market is highly competitive, which helps keep prices stable.
  • Sales Volume: Sales volume is likely to remain stable due to the drug's established use.
  • Revenue: Revenue projections are expected to be consistent with minor adjustments based on market trends.

FAQs

What is Salsalate used for?

Salsalate is used to treat pain, inflammation, and arthritis. It is a nonsteroidal anti-inflammatory drug (NSAID).

Who manufactures Salsalate with NDC 69367-0615?

Salsalate with NDC 69367-0615 is manufactured by Westminster Pharmaceuticals, LLC.

How will the overall pharmaceutical market trends affect Salsalate pricing?

The overall trend of a 3.8% increase in drug prices is expected to have a minimal impact on Salsalate pricing due to its generic nature and the competitive market for NSAIDs.

What role do generic and biosimilar drugs play in the market?

Generic and biosimilar drugs help moderate price increases by providing cheaper alternatives to branded drugs, although they may not directly impact the pricing of Salsalate.

Are there any significant changes expected in the sales volume of Salsalate?

The sales volume of Salsalate is expected to remain stable due to its established use in treating pain and inflammation.

Sources

  1. Find a Code: Westminster Pharmaceuticals, LLC - List of Drugs - NDC Labeler.
  2. Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  5. FDA: National Drug Code Directory.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.